VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q116262601 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010640.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q116262601‏
035 ‎‡a (OCoLC)Q116262601‏
100 0 ‎‡a J. J. Quilligan Jr‏ ‎‡9 fr‏ ‎‡9 en‏ ‎‡9 nl‏ ‎‡9 pt‏ ‎‡9 de‏ ‎‡9 it‏ ‎‡9 sv‏ ‎‡9 pt-br‏ ‎‡9 gl‏ ‎‡9 es‏
670 ‎‡a Author's Adsorption to glass and specific antibody inhibition of iodine-125 labeled influenza virus‏
670 ‎‡a Author's Antiviral Effect of Cyclic Amines on a 1969 Isolate of A 2 Influenza‏
670 ‎‡a Author's Antiviral effect of cyclic amines on a 1969 isolate of A2 influenza.‏
670 ‎‡a Author's Antiviral therapy in abnormally susceptible patients.‏
670 ‎‡a Author's Bone marrow infusion and its complications‏
670 ‎‡a Author's Cat-scratch disease‏
670 ‎‡a Author's CONTINUOUS COBALT-60 IRRADIATION AND IMMUNITY TO INFLUENZA VIRUS‏
670 ‎‡a Author's CULTIVATION OF MYCOPLASMA PNEUMONIAE‏
670 ‎‡a Author's CULTIVATION OF MYCOPLASMA PNEUMONIAE (EATON AGENT)‏
670 ‎‡a Author's Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.*‏
670 ‎‡a Author's Diagnosis of rubella.‏
670 ‎‡a Author's Effect of synthetic smong on spontaneous activity of mice‏
670 ‎‡a Author's Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report‏
670 ‎‡a Author's Further studies on inherited susceptibility to Friend mouse leukemia virus‏
670 ‎‡a Author's Genetic Aspects of Resistance to Friend Leukemia Virus‏
670 ‎‡a Author's Growth of chick aortic endothelial cells: Incorporation of tritiated uridine and thymidine‏
670 ‎‡a Author's GROWTH STIMULATING EFFECTS OF ACID MUCOPOLYSACCHARIDES‏
670 ‎‡a Author's Herpes simplex encephalitis and its neurosurgical implications: report of five cases‏
670 ‎‡a Author's HOMOLOGOUS AND HETEROLOGOUS ANTIBODY RESPONSE OF INFANTS AND CHILDREN TO MULTIPLE INJECTIONS OF A SINGLE STRAIN OF INFLUENZA VIRUS.‏
670 ‎‡a Author's Identification of another epidemic respiratory disease‏
670 ‎‡a Author's Inhibition of lipid synthesis by puromycin in chick aortic cells.‏
670 ‎‡a Author's METABOLIC PARAMETERS OF THE GROWTH-STIMULATING EFFECT OF CHONDROITIN SULFATE A IN TISSUE CULTURES‏
670 ‎‡a Author's MYCOPLASMA PNEUMONIAE‏
670 ‎‡a Author's MYCOPLASMA PNEUMONIAE (EATON ATYPICAL PNEUMONIA AGENT) IN CHILDREN'S RESPIRATORY INFECTIONS.‏
670 ‎‡a Author's Penicillin-resistant pneumococcal meningitis in an immunocompromised infant‏
670 ‎‡a Author's Prevention of atherosclerosis in sub-human primates by chondroitin sulfate A‏
670 ‎‡a Author's Proposal for improved techniques in electron microscopy‏
670 ‎‡a Author's Reactions to an influenza virus vaccine in infants and children.‏
670 ‎‡a Author's Recognition of serum hepatitis‏
670 ‎‡a Author's Resemblance of a strain of swine influenza virus to human A-prime strains‏
670 ‎‡a Author's SEROLOGICAL RESPONSE TO INTRANASAL ADMINISTRATION OF INACTIVE INFLUENZA VIRUS IN CHILDREN.‏
670 ‎‡a Author's STUDIES IN IRON TRANSPORTATION AND METABOLISM. I. CHEMICAL METHODS AND NORMAL VALUES FOR PLASMA IRON AND "EASILY SPLIT-OFF" BLOOD IRON.‏
670 ‎‡a Author's The action of terramycin on the growth of strains of influenza, herpes simplex, and rabies viruses in chick embryos and mice‏
670 ‎‡a Author's The prevention of A2-influenza in children by chemoprophylaxis with amantadine hydrochloride‏
670 ‎‡a Author's The protective effect of polyvalent oil-adjuvant influenza vaccine in chdren‏
670 ‎‡a Author's The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine‏
670 ‎‡a Author's The toxicity of ozone for young chicks‏
670 ‎‡a Author's The treatment of pneumococcal meningitis without intrathecal penicillin‏
670 ‎‡a Author's Type C influenza virus. I. Studies of the virus and its distribution.‏
670 ‎‡a Author's Type C influenza virus. II. Intranasal inoculation of human individuals.‏
919 ‎‡a preventionofa2influenzainchildrenbychemoprophylaxiswithamantadinehydrochloride‏ ‎‡A The prevention of A2-influenza in children by chemoprophylaxis with amantadine hydrochloride‏ ‎‡9 1‏
919 ‎‡a type100influenzavirus2intranasalinoculationofhumanindividuals‏ ‎‡A Type C influenza virus. II. Intranasal inoculation of human individuals.‏ ‎‡9 1‏
919 ‎‡a type100influenzavirus1studiesofthevirusanditsdistribution‏ ‎‡A Type C influenza virus. I. Studies of the virus and its distribution.‏ ‎‡9 1‏
919 ‎‡a treatmentofpneumococcalmeningitiswithoutintrathecalpenicillin‏ ‎‡A The treatment of pneumococcal meningitis without intrathecal penicillin‏ ‎‡9 1‏
919 ‎‡a toxicityofozoneforyoungchicks‏ ‎‡A The toxicity of ozone for young chicks‏ ‎‡9 1‏
919 ‎‡a suppressionofa2influenzainchildrenbythechemoprophylacticuseofamantadine‏ ‎‡A The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine‏ ‎‡9 1‏
919 ‎‡a protectiveeffectofpolyvalentoiladjuvantinfluenzavaccineinchdren‏ ‎‡A The protective effect of polyvalent oil-adjuvant influenza vaccine in chdren‏ ‎‡9 1‏
919 ‎‡a adsorptiontoglassandspecificantibodyinhibitionofiodine125labeledinfluenzavirus‏ ‎‡A Adsorption to glass and specific antibody inhibition of iodine-125 labeled influenza virus‏ ‎‡9 1‏
919 ‎‡a antiviraleffectofcyclicaminesona1969isolateofa2influenza‏ ‎‡A Antiviral Effect of Cyclic Amines on a 1969 Isolate of A 2 Influenza‏ ‎‡9 2‏
919 ‎‡a antiviraltherapyinabnormallysusceptiblepatients‏ ‎‡A Antiviral therapy in abnormally susceptible patients.‏ ‎‡9 1‏
919 ‎‡a bonemarrowinfusionanditscomplications‏ ‎‡A Bone marrow infusion and its complications‏ ‎‡9 1‏
919 ‎‡a catscratchdisease‏ ‎‡A Cat-scratch disease‏ ‎‡9 1‏
919 ‎‡a continuouscobalt60irradiationandimmunitytoinfluenzavirus‏ ‎‡A CONTINUOUS COBALT-60 IRRADIATION AND IMMUNITY TO INFLUENZA VIRUS‏ ‎‡9 1‏
919 ‎‡a cultivationofmycoplasmapneumoniae‏ ‎‡A CULTIVATION OF MYCOPLASMA PNEUMONIAE‏ ‎‡9 1‏
919 ‎‡a cultivationofmycoplasmapneumoniaeeatonagent‏ ‎‡A CULTIVATION OF MYCOPLASMA PNEUMONIAE (EATON AGENT)‏ ‎‡9 1‏
919 ‎‡a demonstrationofinfectioushepatitisvirusinpresymptomaticperiodaftertransferbytransfusion‏ ‎‡A Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.*‏ ‎‡9 1‏
919 ‎‡a diagnosisofrubella‏ ‎‡A Diagnosis of rubella.‏ ‎‡9 1‏
919 ‎‡a effectofsyntheticsmongonspontaneousactivityofmice‏ ‎‡A Effect of synthetic smong on spontaneous activity of mice‏ ‎‡9 1‏
919 ‎‡a experiencewithvaccinationagainstinfluenzainthespringof1947apreliminaryreport‏ ‎‡A Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report‏ ‎‡9 1‏
919 ‎‡a furtherstudiesoninheritedsusceptibilitytofriendmouseleukemiavirus‏ ‎‡A Further studies on inherited susceptibility to Friend mouse leukemia virus‏ ‎‡9 1‏
919 ‎‡a geneticaspectsofresistancetofriendleukemiavirus‏ ‎‡A Genetic Aspects of Resistance to Friend Leukemia Virus‏ ‎‡9 1‏
919 ‎‡a growthofchickaorticendothelialcellsincorporationoftritiateduridineandthymidine‏ ‎‡A Growth of chick aortic endothelial cells: Incorporation of tritiated uridine and thymidine‏ ‎‡9 1‏
919 ‎‡a growthstimulatingeffectsofacidmucopolysaccharides‏ ‎‡A GROWTH STIMULATING EFFECTS OF ACID MUCOPOLYSACCHARIDES‏ ‎‡9 1‏
919 ‎‡a herpessimplexencephalitisanditsneurosurgicalimplicationsreportof5cases‏ ‎‡A Herpes simplex encephalitis and its neurosurgical implications: report of five cases‏ ‎‡9 1‏
919 ‎‡a homologousandheterologousantibodyresponseofinfantsandchildrentomultipleinjectionsofasinglestrainofinfluenzavirus‏ ‎‡A HOMOLOGOUS AND HETEROLOGOUS ANTIBODY RESPONSE OF INFANTS AND CHILDREN TO MULTIPLE INJECTIONS OF A SINGLE STRAIN OF INFLUENZA VIRUS.‏ ‎‡9 1‏
919 ‎‡a identificationofanotherepidemicrespiratorydisease‏ ‎‡A Identification of another epidemic respiratory disease‏ ‎‡9 1‏
919 ‎‡a inhibitionoflipidsynthesisbypuromycininchickaorticcells‏ ‎‡A Inhibition of lipid synthesis by puromycin in chick aortic cells.‏ ‎‡9 1‏
919 ‎‡a metabolicparametersofthegrowthstimulatingeffectofchondroitinsulfateaintissuecultures‏ ‎‡A METABOLIC PARAMETERS OF THE GROWTH-STIMULATING EFFECT OF CHONDROITIN SULFATE A IN TISSUE CULTURES‏ ‎‡9 1‏
919 ‎‡a mycoplasmapneumoniae‏ ‎‡A MYCOPLASMA PNEUMONIAE‏ ‎‡9 1‏
919 ‎‡a mycoplasmapneumoniaeeatonatypicalpneumoniaagentinchildrensrespiratoryinfections‏ ‎‡A MYCOPLASMA PNEUMONIAE (EATON ATYPICAL PNEUMONIA AGENT) IN CHILDREN'S RESPIRATORY INFECTIONS.‏ ‎‡9 1‏
919 ‎‡a penicillinresistantpneumococcalmeningitisinanimmunocompromisedinfant‏ ‎‡A Penicillin-resistant pneumococcal meningitis in an immunocompromised infant‏ ‎‡9 1‏
919 ‎‡a preventionofatherosclerosisinsubhumanprimatesbychondroitinsulfatea‏ ‎‡A Prevention of atherosclerosis in sub-human primates by chondroitin sulfate A‏ ‎‡9 1‏
919 ‎‡a proposalforimprovedtechniquesinelectronmicroscopy‏ ‎‡A Proposal for improved techniques in electron microscopy‏ ‎‡9 1‏
919 ‎‡a reactionstoaninfluenzavirusvaccineininfantsandchildren‏ ‎‡A Reactions to an influenza virus vaccine in infants and children.‏ ‎‡9 1‏
919 ‎‡a recognitionofserumhepatitis‏ ‎‡A Recognition of serum hepatitis‏ ‎‡9 1‏
919 ‎‡a resemblanceofastrainofswineinfluenzavirustohumanaprimestrains‏ ‎‡A Resemblance of a strain of swine influenza virus to human A-prime strains‏ ‎‡9 1‏
919 ‎‡a serologicalresponsetointranasaladministrationofinactiveinfluenzavirusinchildren‏ ‎‡A SEROLOGICAL RESPONSE TO INTRANASAL ADMINISTRATION OF INACTIVE INFLUENZA VIRUS IN CHILDREN.‏ ‎‡9 1‏
919 ‎‡a studiesinirontransportationandmetabolism1chemicalmethodsandnormalvaluesforplasmaironandeasilysplitoffbloodiron‏ ‎‡A STUDIES IN IRON TRANSPORTATION AND METABOLISM. I. CHEMICAL METHODS AND NORMAL VALUES FOR PLASMA IRON AND "EASILY SPLIT-OFF" BLOOD IRON.‏ ‎‡9 1‏
919 ‎‡a actionofterramycinonthegrowthofstrainsofinfluenzaherpessimplexandrabiesvirusesinchickembryosandmice‏ ‎‡A The action of terramycin on the growth of strains of influenza, herpes simplex, and rabies viruses in chick embryos and mice‏ ‎‡9 1‏
996 ‎‡2 SUDOC|161924190
996 ‎‡2 J9U|987007408966105171
996 ‎‡2 LC|nb2011010392
996 ‎‡2 SUDOC|263755118
996 ‎‡2 ISNI|0000000082767846
996 ‎‡2 CAOONL|ncf11919037
996 ‎‡2 PTBNP|1271438
996 ‎‡2 DNB|1351391860
996 ‎‡2 LC|nr2006028465
996 ‎‡2 SUDOC|192726722
996 ‎‡2 SUDOC|027925099
996 ‎‡2 PTBNP|60763
996 ‎‡2 SUDOC|275940268
996 ‎‡2 NTA|181513110
996 ‎‡2 ISNI|0000000073671535
996 ‎‡2 PLWABN|9810633997705606
996 ‎‡2 SUDOC|252847911
996 ‎‡2 ISNI|000000006810320X
996 ‎‡2 DNB|1057739391
996 ‎‡2 SUDOC|167753509
996 ‎‡2 SUDOC|273137824
996 ‎‡2 ISNI|0000000073782075
996 ‎‡2 ISNI|0000000080939472
996 ‎‡2 LC|n 85817171
996 ‎‡2 PTBNP|187596
996 ‎‡2 PTBNP|152247
996 ‎‡2 ISNI|0000000084147667
996 ‎‡2 ISNI|0000000040580311
996 ‎‡2 ISNI|0000000033726212
996 ‎‡2 BIBSYS|1691037120422
996 ‎‡2 SUDOC|250051567
996 ‎‡2 BNE|XX1800602
996 ‎‡2 ISNI|0000000045877560
996 ‎‡2 NTA|352644729
996 ‎‡2 PTBNP|1845843
996 ‎‡2 NTA|27257760X
996 ‎‡2 PTBNP|328452
996 ‎‡2 SUDOC|191870293
996 ‎‡2 LC|n 00090226
996 ‎‡2 CAOONL|ncf11736316
996 ‎‡2 NTA|353011304
996 ‎‡2 DNB|1351252259
996 ‎‡2 NLA|000036581714
996 ‎‡2 ISNI|0000000121388102
996 ‎‡2 DNB|1044447699
996 ‎‡2 SUDOC|268266166
996 ‎‡2 ISNI|0000000440025501
996 ‎‡2 NTA|305151495
996 ‎‡2 JPG|500474643
996 ‎‡2 ISNI|0000000502344728
996 ‎‡2 SUDOC|179749439
996 ‎‡2 SUDOC|181753693
996 ‎‡2 SUDOC|031851916
996 ‎‡2 SUDOC|196454468
996 ‎‡2 ISNI|0000000068181179
996 ‎‡2 ISNI|0000000115258627
996 ‎‡2 LC|no2022020964
996 ‎‡2 DNB|1136749624
996 ‎‡2 SUDOC|18886282X
996 ‎‡2 SUDOC|103667601
996 ‎‡2 PTBNP|1925019
996 ‎‡2 PTBNP|1226247
996 ‎‡2 ISNI|0000000392931699
996 ‎‡2 ISNI|0000000116066213
996 ‎‡2 PTBNP|1551321
996 ‎‡2 ISNI|0000000476986072
996 ‎‡2 ISNI|0000000049813492
996 ‎‡2 SUDOC|161689299
996 ‎‡2 DNB|140244662
996 ‎‡2 NDL|00474417
996 ‎‡2 SUDOC|156625563
996 ‎‡2 ISNI|000000003768964X
996 ‎‡2 ERRR|a12398561
996 ‎‡2 DNB|13819937X
996 ‎‡2 PTBNP|1693225
996 ‎‡2 BNF|18098814
996 ‎‡2 ISNI|0000000031629515
996 ‎‡2 LC|nr2001027575
996 ‎‡2 BLBNB|000534334
996 ‎‡2 ISNI|0000000060120291
996 ‎‡2 LC|n 2004095352
996 ‎‡2 VLACC|000033374
996 ‎‡2 SUDOC|160728479
996 ‎‡2 J9U|987012501905505171
996 ‎‡2 BNE|XX1795249
996 ‎‡2 ISNI|0000000025570609
996 ‎‡2 ISNI|0000000491563422
996 ‎‡2 ISNI|0000000080152012
996 ‎‡2 ISNI|0000000091681040
996 ‎‡2 ISNI|0000000073560261
996 ‎‡2 PTBNP|128815
996 ‎‡2 PTBNP|1283077
996 ‎‡2 DNB|1057701572
996 ‎‡2 DNB|1014512042
996 ‎‡2 DNB|1234739402
996 ‎‡2 BLBNB|001014362
996 ‎‡2 PTBNP|149654
996 ‎‡2 BNF|17244983
996 ‎‡2 BNF|16209148
996 ‎‡2 LC|no2011045374
996 ‎‡2 SUDOC|052199398
996 ‎‡2 ISNI|0000000056710600
996 ‎‡2 ISNI|0000000046010205
996 ‎‡2 BNF|16775176
996 ‎‡2 BLBNB|000530656
996 ‎‡2 ISNI|0000000495697815
996 ‎‡2 LC|n 2012210776
996 ‎‡2 LC|n 2012210672
996 ‎‡2 PTBNP|1188009
996 ‎‡2 SUDOC|248744933
996 ‎‡2 ISNI|0000000035285297
996 ‎‡2 DBC|87097991119196
996 ‎‡2 LC|n 2006218613
996 ‎‡2 DNB|1017227144
996 ‎‡2 ISNI|0000000035524710
996 ‎‡2 BNF|14641393
996 ‎‡2 PTBNP|1750032
996 ‎‡2 ISNI|0000000069421672
996 ‎‡2 ISNI|0000000110531954
996 ‎‡2 ISNI|0000000040977108
996 ‎‡2 DNB|1272641864
996 ‎‡2 NTA|432977317
996 ‎‡2 ISNI|0000000449571955
996 ‎‡2 BNF|17142496
996 ‎‡2 ISNI|0000000114002865
996 ‎‡2 BIBSYS|14067301
996 ‎‡2 PTBNP|129353
996 ‎‡2 ISNI|0000000036205893
996 ‎‡2 PLWABN|9810552080905606
996 ‎‡2 ISNI|0000000081654989
996 ‎‡2 SUDOC|256296278
996 ‎‡2 LC|n 2016257421
996 ‎‡2 BNF|12373420
996 ‎‡2 ISNI|0000000031771757
996 ‎‡2 ISNI|000000005324638X
996 ‎‡2 NUKAT|n 98097423
996 ‎‡2 SUDOC|180348361
996 ‎‡2 PTBNP|1293561
996 ‎‡2 LC|n 87944671
996 ‎‡2 CAOONL|ncf11394730
996 ‎‡2 PTBNP|144481
996 ‎‡2 ISNI|0000000066564627
996 ‎‡2 ISNI|000000011946273X
996 ‎‡2 NYNYRILM|330659
996 ‎‡2 ISNI|0000000036887206
996 ‎‡2 ISNI|0000000078522264
996 ‎‡2 SUDOC|198006365
996 ‎‡2 ISNI|0000000029480950
996 ‎‡2 SUDOC|106913107
996 ‎‡2 PTBNP|1663719
996 ‎‡2 ISNI|0000000376885020
996 ‎‡2 SUDOC|203929926
996 ‎‡2 BNF|16078623
996 ‎‡2 SUDOC|143026879
996 ‎‡2 LC|n 2004104914
996 ‎‡2 ISNI|000000006632878X
996 ‎‡2 LC|n 2009212878
996 ‎‡2 PTBNP|1588229
996 ‎‡2 BNF|14041366
996 ‎‡2 ISNI|0000000029517442
996 ‎‡2 BNF|15995656
996 ‎‡2 BNF|13536485
996 ‎‡2 NTA|069479690
996 ‎‡2 SUDOC|261432389
996 ‎‡2 PTBNP|1790818
996 ‎‡2 ISNI|0000000068823784
996 ‎‡2 SUDOC|068904509
996 ‎‡2 ISNI|0000000044065982
996 ‎‡2 NUKAT|n 2012172878
996 ‎‡2 BLBNB|000231551
996 ‎‡2 SUDOC|129239305
996 ‎‡2 ISNI|0000000140461889
996 ‎‡2 DNB|107222593X
996 ‎‡2 SUDOC|185729568
996 ‎‡2 ISNI|0000000025294974
996 ‎‡2 BNF|16697598
996 ‎‡2 ISNI|0000000373905911
996 ‎‡2 LC|nb2019022043
996 ‎‡2 PTBNP|1641419
996 ‎‡2 DNB|1213497108
996 ‎‡2 SUDOC|118700618
996 ‎‡2 ISNI|0000000359825253
996 ‎‡2 BLBNB|000306114
996 ‎‡2 NKC|ntk20191045561
996 ‎‡2 PTBNP|251238
996 ‎‡2 SUDOC|12258080X
996 ‎‡2 JPG|500001932
996 ‎‡2 ISNI|0000000070126582
996 ‎‡2 ISNI|0000000074182012
996 ‎‡2 ISNI|0000000459685112
996 ‎‡2 SUDOC|085946354
996 ‎‡2 DNB|1023214261
996 ‎‡2 BIBSYS|6008717
996 ‎‡2 ISNI|0000000070308378
996 ‎‡2 ISNI|0000000083454788
996 ‎‡2 NDL|001188922
996 ‎‡2 DNB|1024556859
996 ‎‡2 SUDOC|177546832
996 ‎‡2 PTBNP|148560
996 ‎‡2 ISNI|0000000463628620
996 ‎‡2 BLBNB|001470361
996 ‎‡2 ISNI|0000000088251293
996 ‎‡2 ISNI|0000000074622428
996 ‎‡2 ISNI|0000000109323162
996 ‎‡2 BLBNB|000362739
996 ‎‡2 ISNI|0000000052567720
996 ‎‡2 ISNI|000000006859714X
996 ‎‡2 LC|n 2022027911
996 ‎‡2 ISNI|0000000076965061
996 ‎‡2 SUDOC|200061011
996 ‎‡2 SUDOC|168814994
996 ‎‡2 NTA|318563231
996 ‎‡2 ISNI|0000000381350020
996 ‎‡2 ISNI|0000000034673247
996 ‎‡2 ISNI|0000000067075518
996 ‎‡2 ISNI|0000000373157394
996 ‎‡2 SUDOC|130960543
996 ‎‡2 BLBNB|000618760
996 ‎‡2 ISNI|0000000068410373
996 ‎‡2 SUDOC|175631522
996 ‎‡2 LC|nb2016013334
996 ‎‡2 SUDOC|075080915
996 ‎‡2 ISNI|0000000119496008
996 ‎‡2 DNB|1156279763
996 ‎‡2 PLWABN|9814067825905606
996 ‎‡2 PTBNP|1803067
996 ‎‡2 ISNI|0000000418847103
996 ‎‡2 PTBNP|1491769
996 ‎‡2 ISNI|0000000063318236
996 ‎‡2 ISNI|0000000121332811
996 ‎‡2 SUDOC|158114280
996 ‎‡2 SUDOC|110138007
996 ‎‡2 ISNI|0000000084512951
996 ‎‡2 LC|n 2023255272
996 ‎‡2 LC|n 2024250183
996 ‎‡2 LC|no2023105337
996 ‎‡2 PTBNP|1833180
996 ‎‡2 BNE|XX6171443
996 ‎‡2 DNB|1053282214
996 ‎‡2 JPG|500446670
996 ‎‡2 CAOONL|ncf11669274
996 ‎‡2 ISNI|0000000418934231
996 ‎‡2 DNB|1178164942
996 ‎‡2 ISNI|0000000052566023
996 ‎‡2 ISNI|0000000398367371
996 ‎‡2 BNF|17956081
996 ‎‡2 NTA|425013561
996 ‎‡2 SUDOC|123478413
996 ‎‡2 BNF|12119324
996 ‎‡2 SUDOC|190773294
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏